Kimia Biosciences Ltd
KIMIABLKimia Biosciences Ltd
KIMIABL
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -12.08 | 32.70 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 27.75 | 6.47 | 0.77% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
The company makes bulk drug intermediates. It manufactures bulk drugs intermediates for Indian pharmaceutical companies on contract manufacturing basis. It also offers finish goods and fine chemicals.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2.45 | 0.38 | 2.05 | 77.32 | 95.25 | 107.25 | 135.17 | 125.83 | 129.73 | 101.30 | ||||||||||
Raw Materials | 0.57 | 0.08 | 0.35 | 60.58 | 72.22 | 79.09 | 103.13 | 96.03 | 106.39 | 112.87 | ||||||||||
| Power & Fuel Cost | 0.66 | 0.31 | 0.17 | 1.85 | 2.54 | 3.21 | 4.54 | 6.54 | 7.29 | |||||||||||
| Employee Cost | 1.98 | 2.13 | 0.83 | 7.80 | 8.82 | 10.80 | 14.09 | 15.08 | 16.40 | |||||||||||
| Selling & Administrative Expenses | 0.23 | 0.40 | 0.61 | 2.32 | 2.33 | 3.76 | 4.88 | 6.16 | 7.04 | |||||||||||
| Operating & Other expenses | 0.23 | 0.65 | 0.48 | 1.44 | 2.43 | 4.97 | -2.30 | 0.46 | -2.58 | |||||||||||
EBITDA | -1.22 | -3.19 | -0.39 | 3.33 | 6.91 | 5.42 | 10.83 | 1.56 | -4.81 | -11.57 | ||||||||||
| Depreciation/Amortization | 0.44 | 0.29 | 0.35 | 1.14 | 1.10 | 1.66 | 1.91 | 2.94 | 3.33 | 3.36 | ||||||||||
| PBIT | -1.66 | -3.48 | -0.74 | 2.19 | 5.81 | 3.76 | 8.92 | -1.38 | -8.14 | -14.93 | ||||||||||
| Interest & Other Items | 0.04 | 0.56 | 0.27 | 0.58 | 2.00 | 2.53 | 3.39 | 3.64 | 4.25 | 4.71 | ||||||||||
| PBT | -1.70 | -4.04 | -1.01 | 1.61 | 3.81 | 1.23 | 5.53 | -5.02 | -12.39 | -19.64 | ||||||||||
| Taxes & Other Items | 0.01 | 0.01 | -0.08 | -0.06 | -0.05 | -0.16 | 0.43 | -1.32 | -3.04 | -4.86 | ||||||||||
| Net Income | -1.71 | -4.05 | -0.93 | 1.67 | 3.86 | 1.39 | 5.10 | -3.70 | -9.35 | -14.78 | ||||||||||
| EPS | -2.32 | -5.48 | -1.26 | 1.52 | 2.64 | 0.46 | 1.09 | -0.78 | -1.98 | -3.12 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Kimia Biosciences Ltd | -19.10 | 32.70 | — |
| Sun Pharmaceutical Industries Ltd | 35.09 | 5.01 | 0.93% |
| Cipla Ltd | 35.23 | 4.16 | 0.69% |
| Dr Reddy's Laboratories Ltd | 21.37 | 4.14 | 0.69% |
Price Comparison
Compare KIMIABL with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
KIMIABL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Kimia Biosciences gets recognition for supply of pharmaceutical raw material to Bangladesh
1 year ago•India Infoline
Kimia Biosciences hits the roof after validation in Bangladesh
1 year ago•Business Standard
Stocks that will see action today
1 year ago•The Hindu Businessline
Kimia Biosciences reports standalone net loss of Rs 1.27 crore in the September 2021 quarter
2 years ago•Business Standard
Kimia Biosciences standalone net profit declines 83.84% in the June 2021 quarter
2 years ago•Business Standard
Kimia Biosciences reports standalone net loss of Rs 0.91 crore in the March 2021 quarter
2 years ago•Business Standard
BRIEF-Kimia Biosciences Says Sameer Goel Reappointed Chairman & MD
2 years ago•Investing.com
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 10.9%, vs industry avg of 8.45%
Constant Market Share
Over the last 5 years, market share stayed at 0.04%